New Delhi [India], December 7 (ANI): Bharat Biotech on Monday applied for emergency use authorisation for its indigenously developed COVID-19 vaccine 'Covaxin' to Drugs Controller General of India (DCGI), officials said.
New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country.
New Delhi [India], December 6 (ANI): Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country.
Washington [US], November 21 (ANI): Tech companies Microsoft and Apple are working together to make the Xbox Series X and Series S controllers work on iPhones and iPads.
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Moscow [Russia], October 23 (ANI): The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on Thursday.
New Delhi [India], October 23 (ANI): The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General of India for COVID-19 detection.
Pune (Maharashtra) [India], October 22 (ANI): An Army war trophy--a T-55 tank--was installed on the premises of Principal Controller of Defence Accounts (Officers) here which reflected the close link between the Army and Defence Accounts Department.
New Delhi [India], October 17 (ANI): The expert committee of Drugs Controller General of India (DCGI) on Friday recommended granting permission to Dr Reddy's Laboratories for conducting phase 2 clinical trials of Russian COVID-19 vaccine candidate, Sputnik V, in India, government officials s
New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised application to the Drugs Controller General of India (DCGI) seeking his approval to conduct phase 2 and 3 clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a governm
New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert panel has directed the pharma giant Dr Reddy's Laboratories (DRL) to submit a revised protocol for performing phase 2,3 clinical trials of the Russian COVID-19 vaccine (Sputnik
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia